Fig. 1From: Recent advances of CREKA peptide-based nanoplatforms in biomedical applicationsScheme illustration of the prepared UMFNP-CREKA nanoprobe for imaging ultrasmall metastases by T1-weighted MRI with multiple levels of response [58]Back to article page